Skip to main content
  • Contact Us
  • Subscriber Sign In
Evaluate Logo

navigation

  • What We Do
    • Commercial Intelligence
    • Products
      • Evaluate Pharma
      • Evaluate Omnium
      • Evaluate Medtech
      • Evaluate Epi
      • Japan Drug Forecasts
      • Europe Drug Forecasts
      • CDMO Intelligence
    • Pharma Consulting & Analytics
      • Pharma Consulting & Analytics
      • Data Feeds
    • Evaluate Vantage
      • News
      • Analysis
      • Policy & Pricing
      • Insights
      • Events
      • Medtech
      • Therapy Areas
    • Evaluate for Biotech
  • How We Can Help You
    • Pharma and Biotech
    • Financial Services
    • Management Consultancies
    • Service Providers
    • Customer Testimonials
  • Thought Leadership
    • Multimedia
    • Blog
  • About Us
    • Press Releases
    • Media Coverage
    • Executive Team
    • Vision & History
  • Contact Us
  • Sign Up for Evaluate Vantage
  • Talent
  • Subscriber Sign In

 

Vantage logo

Vantage

  • News
    • Snippets
    • Deals
    • Trial results
    • Patents and litigation
    • Corporate strategy
  • Analysis
    • Interviews
    • Spotlight
    • Vantage points
    • Vantage views
  • Insights
    • M&A
    • IPO
    • NME approvals
    • Quarterly shareprice performance
    • Venture financing
    • Vantage data points
    • Other data
  • Events
    • Company events
    • Conferences
    • Upcoming events
  • Medtech
  • Therapy Areas

Breadcrumb

  1. Home
  2. Vantage
  3. Pharmaceutical Companies
  4. Mako Surgical

Evaluate

Thumbnail
September 05, 2019

Stryker spends $500m to re-up on robots

Deal is the fifth largest robotics surgery purchase ever, and the second big move from Stryker.

July 19, 2016

Zimmer Biomet becomes the latest ortho to go robotic

Vantage logo
February 17, 2016

Stryker to enter top five with $1.3bn Physio-Control buy

Vantage logo
October 30, 2015

Smith & Nephew sees Blue skies in robotic surgery

Vantage logo
June 15, 2015

TransEnterix goes where Intuitive cannot

Vantage logo
January 27, 2014

Medtech M&A picks up in the second half but still disappoints

Vantage logo
January 14, 2014

Smaller cap medtech firms thrive on takeovers but suffer in court

Vantage logo
September 26, 2013

Stryker takes a stride into the future with $1.65bn Mako buy

Vantage logo
July 10, 2013

Intuitive’s poor sales cast a pall over the robotic surgery sector

Vantage logo
April 18, 2013

Victory for Mako as it acquires new tech and hobbles a rival in one move

Vantage logo
March 04, 2013

FDA wonders whether robotic surgery is intuitive after all

Latest Reports

July 27, 2023

H1 Round Up: The haves and the have-nots

July 21, 2023

ADA/EASL eBook

View more...

Editor's Picks

Vantage logo
July 03, 2023

Astrazeneca and Daiichi’s big reveal disappoints

Vantage logo
July 13, 2023

Pharma finds a way to gain weight

Vantage logo
July 03, 2023

Protagonist investors flake as psoriasis pill disappoints

Vantage logo
June 29, 2023

Approaching datasets for big pharma

Vantage logo
June 27, 2023

Nkarta goes back to basics

Open modal

Evaluate Logo

Evaluate HQ
44-(0)20-7377-0800

Evaluate Americas
+1-617-573-9450

Evaluate APAC
+81-80-1164-4754

Footer menu

  • Terms and conditions
  • Privacy Policies
  • Cookie Policy
  • Modern Slavery Statement

© Copyright 2023 Evaluate Ltd.

Sign up